Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FRLN | AZN | AMGN | GILD | VRTX |
| Company | Freeline Therapeutics Holdings Plc Adss | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 6.49 | 92.66 | 328.65 | 124.56 | 456.83 |
| High | 6.49 | 92.88 | 329.37 | 125.00 | 458.36 |
| Low | 6.48 | 92.58 | 327.07 | 123.62 | 455.55 |
| Latest | 6.48 | 92.57 | 327.77 | 123.38 | 456.12 |
| Change | unch | +0.05 | -1.86 | -1.53 | -3.66 |
| % Change | unch | +0.05% | -0.56% | -1.22% | -0.80% |
| Volume | 5,600 | 226,856 | 70,620 | 189,085 | 33,455 |
| 20-Day Average Volume | 9,370 | 5,011,363 | 2,962,095 | 6,704,339 | 1,312,924 |
| Previous Close | 6.48 | 92.52 | 329.63 | 124.91 | 459.78 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.43 | 91.16 | 327.89 | 122.62 | 452.85 |
| 20-Day Raw Stochastic | 92.31% | 93.72% | 49.17% | 61.58% | 82.11% |
| 20-Day Relative Strength | 59.63 | 60.78 | 53.44 | 52.58 | 58.23 |
| Weighted Alpha | +4.30 | +42.97 | +25.48 | +31.97 | +12.42 |
| Today's Opinion | 100% Buy | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 02/09/24 | +1.43% since 12/22/25 | -0.69% since 12/22/25 | -0.24% since 12/22/25 | -0.67% since 12/22/25 |
| Low | 6.40 on 02/12/24 | 91.94 on 12/23/25 | 327.41 on 12/30/25 | 123.83 on 12/30/25 | 456.42 on 12/30/25 |
| High | 6.49 on 02/16/24 | 93.10 on 12/23/25 | 334.38 on 12/24/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | +1.09% since 01/16/24 | +0.15% since 11/28/25 | -4.74% since 11/28/25 | -1.57% since 11/28/25 | +5.44% since 11/28/25 |
| Low | 6.36 on 01/24/24 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 6.49 on 02/16/24 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +37.58% since 11/16/23 | +21.04% since 09/30/25 | +16.62% since 09/30/25 | +11.59% since 09/30/25 | +16.74% since 09/30/25 |
| Low | 4.63 on 11/17/23 | 80.48 on 11/04/25 | 283.00 on 10/01/25 | 108.46 on 10/02/25 | 392.49 on 10/01/25 |
| High | 6.55 on 12/05/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | +65.73% since 08/16/23 | +32.88% since 06/30/25 | +17.87% since 06/30/25 | +11.72% since 06/30/25 | +2.70% since 06/30/25 |
| Low | 2.60 on 10/06/23 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 7.70 on 11/03/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,129 | 286,946,304 | 177,499,504 | 154,973,344 | 116,654,920 |
| Shares Outstanding, K | 4,341 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -88,970,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 10,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -12,090,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.66 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 12/01/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 04/02/24 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.33 | 15.22 | 15.23 | 30.24 |